Month of birth is associated with multiple sclerosis but not with HLA-DR15 in Finland

Multiple Sclerosis Journal

Volumn 18, Issue 5, 2012, Pages 563-568

  Saastamoinen, Kari Pekka ^a   Auvinen, Marja Kaisa ^b   Tienari, Pentti J ^a,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Finnish Red Cross   (Finland)

^c BIOMEDICUM HELSINKI   (Finland)

Author keywords

epidemiology; HLA; multiple sclerosis; season of birth; vitamin D

Indexed keywords

HLA DR15 ANTIGEN;

ARTICLE; BIRTH; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FINLAND; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MONTH; MONTH OF BIRTH; MULTIPLE SCLEROSIS; RISK; SEASON; SPRING; TIME;

EID: 84860431139     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458511426814     Document Type: Article

References (27)

1. Templer DI, Trent NH, Spencer DA, et al. Season of birth in multiple sclerosis. Acta Neurol Scand. 1992 ; 85: 107-109
2. Willer CJ, Dyment DA, Sadovnick AD, Rothwell PM, Murray TJ, Ebers GC. Timing of birth and risk of multiple sclerosis: population based study. BMJ. 2005 ; 330: 120
3. Bayes HK, Weir CJ, O'Leary C. Timing of birth and risk of multiple sclerosis in the Scottish population. Eur Neurol. 2009 ; 63: 36-40
4. Staples J, Ponsonby AL, Lim L. Low maternal exposure to ultraviolet radiation in pregnancy, MOB, and risk of multiple sclerosis in offspring: longitudinal analysis. BMJ. 2010 ; 340: c1640
5. Sadovnick AD, Duquette P, Herrera B, et al. A timing-of-birth effect on multiple sclerosis clinical phenotype. Neurology. 2007 ; 69: 60-62
6. Ramagopalan SV, Link J, Byrnes JK, et al. HLA-DRB1 and month of birth in multiple sclerosis. Neurology. 2009 ; 73: 2107-2111
7. Handunnetthi L, Ramagopalan SV, Ebers GC. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology. 2010 ; 74: 1905-1910
8. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens. 1991 ; 38: 1-15
9. Lincoln MR, Montpetit A, Cader MZ, et al. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Nat Genet. 2005 ; 37: 1108-1112
10. Ramagopalan SV, Maugeri NJ, Handunnetthi L, et al. Expression of the multiple sclerosis-associated MHC class II Allele HLA-DRB1*1501 is regulated by vitamin D. PLoS Genet. 2009 ; 5: e1000369
11. Chabas D, Taheri S, Renier C, Mignot E. The genetics of narcolepsy. Annu Rev Genomics Hum Genet. 2003 ; 4: 459-483
12. Dauvilliers Y, Carlander B, Molinari N, et al. Month of birth as a risk factor for narcolepsy. Sleep. 2003 ; 26: 663-665
13. Sumelahti ML, Tienari PJ, Wikström J, et al. Regional and temporal variation in multiple sclerosis incidence in Finland during 1979-93. Neuroepidemiology. 2000 ; 19: 67-75
14. Sumelahti ML, Tienari PJ, Wikström J, et al. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand. 2001 ; 103: 153-158
15. Kokkonen J, Koivisto M, Kirkinen P. Seasonal variation in serum-25-OH-D3 in mothers and newborn infants in northern Finland. Acta Paediatr Scand. 1983 ; 72: 93-96
16. Lamberg-Allardt C, Ala-Houhala M, Ahola M, Parviainen MT, Räsänen L, Visakorpi J. Vitamin D status of children and adolescents in Finland. Ann Nutr Metab. 1986 ; 30: 267-272
17. Laaksonen M, Pastinen T, Sjöroos M, et al. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol. 2002 ; 122: 140-145
18. Bonetti A, Koivisto K, Pirttilä T, et al. A follow-up study of chromosome 19q13 in multiple sclerosis susceptibility. J Neuroimmunol. 2009 ; 208: 119-124
19. Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 ; 476: 214-219
20. Westman P, Kuismin T, Partanen J, Koskimies S. An HLA-DR typing protocol using group-specific PCR-amplification followed by restriction enzyme digests. Eur J Immunogenet. 1993 ; 20: 103-109
21. Sirén MK, Sareneva H, Lokki ML, Koskimies S. Unique HLA antigen frequencies in the Finnish population. Tissue Antigens. 1996 ; 48: 703-707
22. Ramagopalan SV, Heger A, Berlanga AJ, et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 2010 ; 20: 1352-1360
23. Rothwell PM, Staines A, Smail P, et al. Seasonality of birth of patients with childhood diabetes in Britain. BMJ. 1996 ; 312: 1456-1457
24. Vaiserman AM, Carstensen B, Voitenko VP, et al. Seasonality of birth in children and young adults (0-29 years) with type 1 diabetes in Ukraine. Diabetologia. 2007 ; 50: 32-35
25. Rothwell PM, Gutnikov SA, McKinney PA, Schober E, Ionescu-Tirgoviste C, Neu A. Seasonality of birth in children with diabetes in Europe: multicentre cohort study. BMJ. 1999 ; 319: 887-888
26. Åkerblom HK, Vaarala O, Hyöty H, et al. Environmental factors in the etiology of type 1 diabetes. Am J Med Genet. 2002 ; 115: 18-29
27. Thorsby E, Rønningen KS. Role of HLA genes in predisposition to develop insulin-dependent diabetes mellitus. Ann Med. 1992 ; 24: 523-531